Head of Immunology and Multiple Sclerosis, Asset Development and Portfolio Management (ADPM)
Professional Diversity Network
Research Triangle Park, Durham, NC, USA
About This Role
The Pharmaceutical Operations and Technology (PO&T) Head of Immunology and Multiple Sclerosis will work closely with other executive leaders to define and execute strategic imperatives to advance Biogen's portfolio of pre-clinical, clinical, and commercial assets -- including drug development towards NDA/BLA/MAA, launch, customer focused and prioritization of life cycle management (LCM) activities. This role will have in-depth expertise in drug development (modality agnostic and all phases of development). They will implement and maintain best practices for resource management/forecasting, decision gates, and learning agility in all modalities. They will also take a leading role for PO&T in partnerships/collaborations and serve as the PO&T representative facing Business Development/External Innovation to evaluate external assets and potential M&As. In this capacity, the Head of Immunology and Multiple Scleoris works extensively with other PO&T, R&D, Commercial, Medical and Affiliates functions to ensure cross-company alignment.
This role is also accountable for delivering a 5-year PO&T asset strategy for each product under their purview and the maintenance and execution of an 18-month rolling tactical plan, monitoring key program risks and developing mitigation plans. Additionally, this leader will be accountable for all the deliverables of the assets.
Reporting directly to the head of Immunology will be between 3-7 asset leaders with cross-functional leadership responsibilities for multiple teams in PO&T and will be representing PO&T at the appropriate forums at Biogen and joint steering and manufacturing committees.
This is a hybrid role that can be based either at our Cambridge, MA office or RTP, NC office.
What You'll Do
Oversee the development and execution of the PO&T Product Development Strategy for assets at all stages, from early clinical development through launch, commercialization, and life cycle management. Identify risks and remove barriers in order to deliver on the portfolio to ensure timelines are met within budget.
Provide leadership to the Asset Leads and cross-functional teams to drive collaboration, integrations, and efficiencies across development program activities and functional departments.
Serve as the PO&T asset owner for at least one late-stage asset/commercial asset and serve as a PO&T representative at the Product Development and Commercialization (PDC)Team with accountability to bringing the PO&T viewpoint to the PDC and bringing the PDC viewpoint back to PO&T as well as contributing to the strategy and tactical plan.
Lead the asset(s) cross-functional PO&T asset team in the delivery on the PO&T Asset Strategy and Tactical plan. Develop business cases for key asset initiatives and secure management endorsement at PO&T governance anage synergy with line functions with regards to resources and budget allocation and drives best practices in partnership with Finance and Business Planning. Develop metrics to support decisions, development timelines.
Who You Are
You are a seasoned leader with in-depth experience in drug development. You will be part of ADPM where you will work closely with the PO&T leadership team to make appropriate decisions in a timely manner that will impact the entire organization. You will play an instrumental role in leading and facilitating key aspects of the PO&T vision including Modality Agility by being modality-agnostic; Influence & Collaboration through engagement with/oversight of all collaborations and interface with Business Development and External Innovation; Data Access and Connectivity by driving best practices for resource management/forecasting decision gates and associated knowledge management initiatives.
Minimum of 15+ years of relevant experience in the biopharmaceutical industry.
PhD in pharmaceutical-related field. Advanced degree with commensurate experience may be considered). PhD preferable, or MS with many years of experience.
Demonstrated experience in leading/facilitating complex team engagements and partnerships in a highly matrixed, fast-growing and global biopharmaceutical organization, and broad technical knowledge in all modalities and phases of drug development.
Exceptional leadership abilities in a matrixed organization.
Proven success in managing complex development portfolios and project plans.
Deep technical expertise and strategic thinker.
Developing internal talent.
Excellent communication, negotiation, problem solving and decision-making abilities.
Demonstrated ability to influence without authority.
Our mission to find therapies for neurological and rare diseases is a unique focus within our industry and this shared purpose is what connects us as a team. We work together to overcome obstacles and to follow the science. We are resilient as we strive to make an impact on our patients' lives and on changing the course of medicine. Together, we pioneer. Together, we thrive.
At Biogen, we are committed to building on our culture of inclusion and belonging that reflects the communities where we operate and the patients we serve. We know that diverse backgrounds, cultures, and perspectives make us a stronger and more innovative company, and we are focused on building teams where every employee feels empowered and inspired. Read on to learn more about our DE&I efforts.
All qualified applicants will receive consideration for employment without regard to sex, gender identity or expression, sexual orientation, marital status, race, color, national origin, ancestry, ethnicity, religion, age, veteran status, disability, genetic information or any other basis protected by federal, state or local law. Biogen is an E-Verify Employer in the United States.